Bacterial Enzyme ApaH Decaps RNA Stress Signals Using Two Binding Orientations

Dinucleoside tetraphosphates (Np4Ns) are ancient, enigmatic molecules found across all domains of life whose intracellular concentrations spike dramatically during bacterial stress. Recent discoveries showed these 'alarmones' can be incorporated as caps on the 5′ ends of bacterial mRNAs and small RNAs, linking cellular stress signals directly to gene regulation. In E. coli, the enzyme ApaH is the primary enzyme responsible for removing these caps under non-stressed conditions, thereby initiating 5′-end-dependent RNA degradation. Understanding ApaH's mechanism has become urgent given that its deletion sensitizes bacteria to antibiotics and stress — making it a promising target for antibiotic potentiators.

The research team conducted a comprehensive biochemical and structural investigation of E. coli ApaH, solving multiple X-ray crystal structures: the apo enzyme, enzyme bound to nucleoside diphosphate (NDP) products (ADP, GDP, CDP, UDP), enzyme bound to Np4N substrates, and enzyme bound to NAD+. They found that ApaH harbors a binuclear manganese (Mn2+) cluster at its catalytic core, with a precisely positioned water molecule (W1) primed for in-line nucleophilic attack on the β-phosphate of the substrate. Mn2+ ions dramatically accelerate catalysis (~100-fold versus Mg2+ alone), and a 'triple fork' arrangement of Asn65, Arg184, and Lys197 residues recognizes the distal γ and δ phosphates of Np4N substrates.

In biochemical experiments, ApaH hydrolyzed all tested Np4N variants (symmetric and asymmetric) at similar rates, differing by no more than 3-fold, demonstrating broad substrate promiscuity. For RNA decapping, the enzyme showed no significant preference based on the number of unpaired 5′ nucleotides, the nucleotide identity at the +1 position, or the nucleobase within the cap itself. Importantly, this promiscuity extended to diverse biologically relevant targets: ApaH efficiently decapped multiple mRNAs and small RNAs (sRNAs), directly influencing their cellular half-lives.

The most mechanistically significant finding was that ApaH can bind its Np4N and Np4-RNA substrates in two alternative orientations within the active site. Structural analysis showed the nucleoside binding site (the 'position 0' pocket) is shallow and primarily aliphatic, relying on non-specific CH-π interactions with Trp249 and Ser230 rather than sequence-specific hydrogen bonds. This near-symmetric recognition allows substrates to dock with either nucleoside in the binding pocket. Molecular dynamics simulations supported the notion that one orientation is moderately preferred, but both are catalytically productive and generate the same cleavage products (NDPs and ppRNA).

These findings carry direct implications for drug development. Inhibitors designed to mimic the substrate in one orientation — a common rational drug design strategy — may fail to block catalysis if the enzyme simply accommodates the inhibitor or natural substrate in the alternative orientation. This 'orientation escape' mechanism should be considered when targeting ApaH or structurally similar enzymes with pseudo-symmetric substrates. The study establishes E. coli ApaH as a prototype for the symmetric class of Np4N hydrolases and provides the most detailed mechanistic framework yet for this enzyme family.